Fiera Capital Corp Blueprint Medicines Corp Transaction History

Fiera Capital Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$45.57 - $74.26 $985,906 - $1.61 Million	-21,635 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$58.91 - $78.32 $794,695 - $1.06 Million	-13,490 Reduced 38.41%	21,635 $1.69 Million
Q2 2018 Aug 02, 2018	BUY	$60.96 - $101.18 $2.14 Million - $3.55 Million	35,125 New	35,125 $2.23 Million

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.4B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Fiera Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Fiera Capital Corp with notifications on news.